Genetic diagnostics and precision medicine for rare disease diagnosis across 100+ countries
CENTOGENE operates a global genetic diagnostics platform built on Illumina sequencing hardware and Salesforce-anchored operations, serving physicians and pharma companies focused on rare and orphan diseases. The company is mid-stage in geographic expansion—actively establishing its first APAC laboratory operations in Taiwan while scaling support and sales infrastructure across six countries—yet the tech stack shows reliance on legacy enterprise tools (Dynamics 365, Excel, Salesforce) with no active tech migrations, suggesting operational maturity but potential tooling friction as labs multiply across regions.
Notable leadership hires: Business Director
CENTOGENE is a publicly traded genetic diagnostics company headquartered in Rostock, Germany, founded in 2006. The company diagnoses rare diseases through Next Generation Sequencing and biochemical analysis, drawing on a genetic database of over one million individuals. Operations span more than 100 countries, with partnerships across clinical and pharmaceutical sectors. Current focus is geographic expansion into APAC markets, particularly Taiwan, while managing compliance, laboratory operations, and sales enablement across multiple regions.
CENTOGENE uses Illumina sequencing platforms, Salesforce for CRM, Microsoft Dynamics 365 for enterprise resource planning, Microsoft 365 productivity suite, Cisco Meraki for networking, Palo Alto Networks for security, and VMware for infrastructure virtualization.
CENTOGENE has 17 active roles across six countries: Germany, Brazil, Taiwan, Spain, United Arab Emirates, and Poland. Recent hires focus on support (5), sales (4), and finance (3) roles.
CENTOGENE is establishing its first APAC laboratory operations in Taiwan and is actively expanding into APAC markets more broadly, while managing distributor network development and compliance with regional diagnostics regulations.
Other companies in the same industry, closest in size